agilon health, inc.

The momentum for this stock is not very good. agilon health, inc. is not a good value stock. agilon health, inc. has good growth characteristics. agilon health, inc. is not very popular among insiders. agilon health, inc. is a mediocre stock to choose.
Log in to see more information.
AGL Fundamental Data by TradingView

News

agilon health to Participate at 2024 Wells Fargo Healthcare Conference
agilon health to Participate at 2024 Wells Fargo Healthcare Conference

Business Wire agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 2024 Wells Fargo Healthcare...\n more…

Market Cool On agilon health, inc.'s (NYSE:AGL) Revenues Pushing Shares 34% Lower
Market Cool On agilon health, inc.'s (NYSE:AGL) Revenues Pushing Shares 34% Lower

Simply Wall St agilon health, inc. ( NYSE:AGL ) shares have had a horrible month, losing 34% after a relatively good period...\n more…

Agilon Health price target lowered by $1 at Deutsche Bank
Agilon Health price target lowered by $1 at Deutsche Bank

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating Agilon Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating Agilon Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Globe Newswire NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. (NYSE...\n more…

Agilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Agilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Investment Research Agilon Health (AGL) reported $1.48 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 29%. EPS of -$0.07 for the same period compares to -$0.04 a year...\n more…

Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates
Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates

Zacks Investment Research Agilon Health (AGL) came out with a quarterly loss of $0.07 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.04 per share a year ago. These figures are adjusted for...\n more…